MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202547033943 A) filed by Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Heidelberg, Germany, on April 7, for 'modified oncolytic parvovirus h 1pv with an enhanced fitness and superior anticancer activity.'
Inventor(s) include Li Junwei; Autenrieth Stella; Richter Karsten; Hofmann Ilse; Tessmer Claudia; and Puschhof Jens.
The application for the patent was published on May 2, under issue no. 18/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a rodent H 1 parvovirus variant capable of propagating and spreading through human tumor cells. In particular the present invention...